Nnadozie Emechebe, PhD, BPharm

AbbVie Inc.

Poster(s):

• 1412 - Real-world Utilization of Novel Therapies and Overall Survival among U.S. Medicare Beneficiaries Initiating Frontline Chronic Lymphocytic Leukemia Treatment

• 1803 - Real-world Treatment Outcomes among Patients with High-Risk CLL/SLL Receiving Venetoclax-Based Therapy in 1L or 2L: An Updated International Study